v3.26.1
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit - USD ($)
Common stock
Additional Paid in Capital
Accumulated Other Comprehensive Income (Loss)
Treasury stock
Accumulated Deficit
Common stock to be issued
Total
Balance at Dec. 31, 2024 $ 87 $ 27,643,660 $ (47,777) $ (127,500) $ (44,099,813)   $ (16,631,343)
Balance (in Shares) at Dec. 31, 2024 8,721,818            
Foreign currency translation income (loss) (1,935)   (1,935)
Issuance of common stock for loan financing $ 1 117,647     117,648
Issuance of common stock for loan financing (in Shares) 30,360            
Net (loss) income 876,264   876,264
Balance as of March 31, 2025 at Mar. 31, 2025 $ 88 27,761,307 (49,712) (127,500) (43,223,549)   (15,639,366)
Balance as of March 31, 2025 (in Shares) at Mar. 31, 2025 8,752,178            
Balance at Dec. 31, 2025 $ 114 33,594,550 (154,281) (127,500) (56,441,021) (23,128,138)
Balance (in Shares) at Dec. 31, 2025 11,483,926            
Foreign currency translation income (loss) 22,080 22,080
Fair value of vested stock options 116,307 116,307
Common stock to be issued for accounts receivable advance financing 153,400 153,400
Net (loss) income (2,568,899) (2,568,899)
Balance as of March 31, 2025 at Mar. 31, 2026 $ 114 $ 33,710,857 $ (132,201) $ (127,500) $ (59,009,920) $ 153,400 $ (25,405,250)
Balance as of March 31, 2025 (in Shares) at Mar. 31, 2026 11,483,926